Blue Star Ltd (BLUESTARCO)
₹1,460.90
Mkt cap
₹30,760 Cr
P/E ratio
58.10
P/B
8.75
Div yield
0.57%
ROE
17.20%
ROCE
21.20%
EPS (TTM)
₹25.14
Book value
₹167
52W range
1,445–2,017
Sector
Consumer Discretionary
Price history
Previous close
Blue star manufacturers air purifiers, air coolers, water purifiers, cold storage and speciality products. The Company offers turnkey solutions in MEP (Mechanical, Electrical, Plumbing, and Fire-fighting) Projects. It is the largest after-sales service provider for air conditioning and commercial refrigeration products in the country. [1] [2]
NSE BLUESTARCOBSE 500067
Health check
Cautious
ValuationExpensive
ProfitabilityStrong
GrowthModerate
TechnicalsBearish
52-week range
−27.56% from high₹1,461
₹1,445+1.08% from low₹2,017
Current
₹1,460.90
Prev close
₹1,496.00
Day
−2.35%
Price performance
1D
−2.35%
1W
−2.01%
1M
−3.12%
3M
−7.64%
6M
−24.96%
1Y
−24.71%
YTD
−19.56%
Financials
Revenue, profit & margin
P/E ratio
58.1×
BLUESTARCO is 53% above the sector median of 38.1×
BLUESTARCO58.1×
Sector median38.1×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,226 | 1,890 | 2,241 | 3,328 | 2,865 | 2,276 | 2,807 | 4,019 | 2,982 | 2,422 | 2,925 | 4,072 | 3,378 | |
| Expenses | 2,081 | 1,768 | 2,086 | 3,086 | 2,628 | 2,127 | 2,599 | 3,740 | 2,784 | 2,240 | 2,705 | 3,746 | 3,203 | |
| Operating Profit | 145 | 123 | 155 | 242 | 238 | 149 | 209 | 279 | 199 | 182 | 220 | 326 | 175 | |
| OPM % | 7% | 6% | 7% | 7% | 8% | 7% | 7% | 7% | 7% | 8% | 8% | 8% | 5% | |
| Other Income | 9 | 13 | 13 | 13 | 24 | 19 | 21 | 24 | 16 | 10 | -44 | 45 | 30 | |
| Interest | 18 | 18 | 10 | 12 | 8 | 6 | 16 | 19 | 10 | 17 | 22 | 23 | 13 | |
| Depreciation | 23 | 23 | 23 | 28 | 28 | 30 | 35 | 35 | 41 | 43 | 46 | 48 | 57 | |
| Profit before tax | 114 | 95 | 134 | 214 | 226 | 131 | 179 | 249 | 163 | 132 | 108 | 300 | 135 | |
| Tax % | 27% | 26% | 25% | 25% | 25% | 27% | 26% | 22% | 26% | 25% | 25% | 24% | 24% | |
| Net Profit | 83 | 71 | 100 | 160 | 169 | 96 | 132 | 194 | 121 | 99 | 81 | 227 | 103 | |
| EPS in Rs | 4.33 | 3.44 | 4.88 | 7.81 | 8.21 | 4.68 | 6.45 | 9.42 | 5.88 | 4.82 | 3.92 | 11.04 | 4.99 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.37% · closed higher next day 26 of last 58
| Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 30 Oct '23◦ | 30 Jan '24◦ | 2 May '24◦ | 6 Aug '24◦ | 6 Nov '24◦ | 29 Jan '25◦ | 7 May '25◦ | 6 Aug '25 | 5 Nov '25◦ | 29 Jan '26◦ | 6 May '26◦ | 6 Aug '26 |
| Earnings day | +1.43% | +3.57% | −1.54% | +2.06% | −5.45% | −1.61% | −4.14% | +1.13% | −6.89% | +4.87% | −3.21% | −3.63% |
| +1 day | +7.12% | +7.69% | −1.61% | +1.87% | −4.97% | −0.54% | −4.99% | +4.39% | −8.60% | +6.10% | −6.30% | −4.01% |
| +5 days | +9.81% | +6.23% | −3.75% | +8.46% | −3.86% | +7.75% | −6.34% | +0.29% | −6.77% | +8.57% | −7.72% | −4.01% |
| +15 days | +11.82% | +15.57% | +0.99% | +6.70% | −2.06% | +3.85% | −7.55% | +7.48% | −8.31% | +13.62% | −12.04% | −5.79% |
| +30 days | +13.98% | +14.59% | +18.07% | +17.45% | +6.63% | +10.84% | −5.13% | +12.17% | −3.29% | +4.13% | −7.66% | — |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 months| Kind | Value | Ex-date | Record |
|---|---|---|---|
| dividend Dividend - Rs 8.50 Per Share | 8.50 | 17 Jul '26 | 17 Jul '26 |
Shareholding
as of Jun 202636.49%Promoter
Promoters36.49%0.01
FIIs12.75%1.05
DIIs28.24%0.46
Public22.49%0.57
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| LGEINDIA | ₹1,647.80 | 61.30 | 1,11,848 | 0.00% | 653 | +27.20% | 7,233 | +15.49% | 32.27% |
| VOLTAS | ₹1,167.20 | 82.71 | 38,621 | 0.34% | 213 | +52.19% | 4,674 | +18.66% | 9.04% |
| BLUESTARCO | ₹1,496.00 | 58.13 | 30,760 | 0.57% | 103 | −21.03% | 3,378 | +13.27% | 21.24% |
| AMBER | ₹7,439.00 | 127.15 | 26,236 | 0.00% | 3 | −3.37% | 3,888 | +12.72% | 10.29% |
| CROMPTON | ₹231.02 | 32.77 | 14,876 | 1.30% | 140 | +12.12% | 2,022 | +11.20% | 18.98% |
| VGUARD | ₹332.55 | 38.23 | 14,530 | 0.45% | 130 | +76.37% | 1,811 | +23.50% | 18.38% |
| WHIRLPOOL | ₹815.35 | 37.94 | 10,344 | 0.61% | 103 | −29.40% | 2,727 | +12.10% | 10.67% |
| Median: 23 Co. | ₹548.00 | 38.08 | 3,949 | 0.34% | 32 | +29.34% | 886 | +17.10% | 10.93% |
Filings
Annual reports15
Annual Report 2026bseAnnual Report 2025bseAnnual Report 2024bseAnnual Report 2023bseAnnual Report 2022bseAnnual Report 2021bseAnnual Report 2020bseAnnual Report 2019bseAnnual Report 2018bseAnnual Report 2017bseAnnual Report 2016bseAnnual Report 2015bseAnnual Report 2014bseAnnual Report 2013bseAnnual Report 2012bse
Concall transcripts96
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024PPTNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Sep - Blue Star schedules analyst/investor meetings on September 10 and 16, 2026 in Mumbai and Gurugram.Announcement Under Regulation 30 (LODR) - Update On Completion Of Sale And Transfer Of Medtech Business Of Blue Star Engineering & Electronics Limited, A Wholly Owned Subsidiary Of The Company 2 Sep - Blue Star completed sale of MedTech business to Cyrix effective September 1, 2026, for up to Rs 40 crore.Announcement under Regulation 30 (LODR)-Restructuring 14 Aug - Blue Star E&E signed BTA on August 14, 2026 to sell MedTech division to Cyrix for up to Rs 40 crore, completion by March 31, …Announcement under Regulation 30 (LODR)-Earnings Call Transcript 13 AugAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 7 Aug - Audio recording of Q1 FY27 investors’ conference call made available on company website.